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HF patients is their younger age, smaller number 
of comorbidities, and a different clinical course 
of the disease, including a higher likelihood of 
beneficial left ventricular reverse remodeling. 
Precise evaluation of risks in DCM patients is 
of utmost importance, so that appropriate life 
counselling can be provided (eg, family plan‑
ning, career guidance), treatment can be guid‑
ed reliably (eg, step ‑up or step ‑down; ICD rec‑
ommendations, appropriate timing of heart 
transplantation) and the clinical course of the 
disease can be predicted. In the upcoming era 
of tailored medicine, the evaluation of disease ‑
‑inherent risks is not merely an academic issue 
but the cornerstone of individualized manage‑
ment. Hence, modern cardiology is at the fore‑
front of scale ‑dedicated research, and there are 
now many validated and newly ‑published scales, 
including a score evaluatingthromboembolic 
risk in AF.4
Although the number of HF scales is consid‑
erable, they are all based on general HF cohorts, 
consisting mostly of patients with ischemic HF. 
Consequently, their application in DCM is some‑
what questionable. Surprisingly, there is still no 
scale applicable specifically to DCM. Therefore, 
to respond to this yet unmet clinical need, we 
developed a scale based on a fairly large DCM 
population. Briefly, we analyzed the records 
of 406 DCM patients during 48.2 months of 
follow ‑up.5 Initially, we examined 8 most pop‑
ular HF prognostic scales in DCM and found 
that all of them overestimated the true mortal‑
ity risks. Next, we built a unique linear model 
based on 21 parameters, including clinical, elec‑
trocardiographic, echocardiographic, and labo‑
ratory parameters, as well as the applied treat‑
ment. This newly ‑developed Krakow DCM Risk 
Score (Krakow ‑DCM) provided the best accu‑
racy and discriminative power in comparison 
with all other HF models. Although the number 
of required parameters is relatively large, all of 
them are readily available in DCM patients. Fur‑
thermore, the Krakow ‑DCM model supplies the 
To the editor We read with great interest the 
recent paper by Kucharz and Kułakowski1 pub‑
lished in the November 2020 issue of Kardio‑
logia Polska (Kardiol Pol, Polish Heart Journal), 
in which the authors raised the important is‑
sue of arrhythmic events (AEs) occurrence and 
implantable cardioverter ‑defibrillator (ICD) in‑
terventions in patients with heart failure (HF). 
The finding regarding the predictive role of frag‑
mented QRS (fQRS) in AE gives rise to a much ‑
‑needed discussion on the novel management 
of ICD implantation. Given the lack of any clear 
benefits stemming from ICD implantation in 
unselected patients with dilated cardiomyop‑
athy (DCM), as shown in the previous studies, 
and the significant association between appro‑
priate ICD interventions and ischemic etiology 
of HF reported by Winkler et al2, we would like 
to give some consideration to the significant 
predictors of AE in DCM, especially due to the 
fact that in the analysis presented by Kucharz 
and Kułakowski,1 DCM patients constituted a 
quarter of the study population.
Notably, none of the HF guidelines differen‑
tiate the management strategies based on eti‑
ology, whereas a growing body of evidence sug‑
gests potentially different levels of risk for AE 
and nonhomogenous benefits arising from pro‑
phylactic ICD implantations in HF. These obser‑
vations are particularly relevant in the context 
of the novel therapy with angiotensin receptor 
neprilysin inhibitors, which reduces the risk for 
AE.3 Therefore, novel predictors of AE and ap‑
propriate ICD shocks are eagerly awaited and 
much sought ‑after in HF and DCM. Bearing in 
mind the recent important discovery of Kucharz 
and Kułakowski regarding the predictive role of 
fQRS in determination of AE risk in the gener‑
al HF cohort, we are wondering whether there 
is any relationship between fQRS and HF etiol‑
ogy (ie, ischemic vs nonischemic HF).
As is well ‑known, nearly 1 in 5 patients with 
HF and reduced ejection fraction has DCM. 
What makes DCM patients different from other 
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However, Sha et al2 found that fQRS in patients 
with idiopathic DCM was a predictor of higher 
total mortality and higher incidence of arrhyth‑
mic events. Moreover, based on the fact that the 
presence of fQRS is associated with myocardi‑
al scar regardless of its etiology,3 it seems rea‑
sonable to expect that this parameter could be 
linked with adverse cardiac events. Given a rel‑
atively low number of arrhythmic events in the 
general population of DCM patients with ICD, 
risk stratification in this group remains a chal‑
lenge. The fQRS appears to be a promising pre‑
dictive parameter; however, further research in 
this area is required.
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linear probability of death and allows the calcu‑
lation of individual mortality risk in 1 to 5 years.
We strongly believe that application of the 
Krakow ‑DCM model in daily management of 
DCM patients may significantly help to rede‑
fine the risks and guide the clinical manage‑
ment, for example, by enabling a more accurate 
referral for ICD therapy. It is quite possible that 
validation of the fQRS as a predictive factor and 
its incorporation (if proven to be of value) into 
the Krakow ‑DCM model may further bolster the 
predictive power of this risk score.
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Authors’ reply We would like to thank 
Dziewięcka and Rubiś for their interest in our 
research. We previously showed that fragment‑
ed QRS (fQRS) was a frequent finding in patients 
with implantable cardioverter ‑defibrillators 
(ICDs).1 It was more common in those with isch‑
emic cardiomyopathy than with dilated cardio‑
myopathy (DCM), more advanced heart failure 
and coronary artery disease, higher number of 
comorbidities, and altered ECG repolarization. 
It was also present more often in a subgroup 
with ICD implanted for secondary than for pri‑
mary prevention.
In the present study, we showed that fQRS in 
inferior ECG leads was a risk factor for appro‑
priate ICD shocks in the whole ICD population. 
Unfortunately, a separate subgroup analysis of 
DCM patients was not possible due to the limit‑
ed number of patients with both DCM and fQRS. 
